Literature DB >> 12519302

Tumour necrosis factor-alpha is a fundamental cytokine in autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide in interleukin-12 p40 deficient C57BL/6 mice.

Paola Zaccone1, Zoltán Fehérvári, Anne Cooke.   

Abstract

Experimental autoimmune thyroiditis (EAT) is inducible in mice by immunization with mouse thyroglobulin (mTg) together with adjuvant, either lipopolysaccharide (LPS) or complete Freund's adjuvant (CFA). The severity of the disease is dependent on the mouse strain and on the adjuvant used. We have previously shown that interleukin (IL)-12 deficient C57BL/6 mice immunized with mTg and CFA develop a significantly less severe thyroid infiltration in comparison to wild type C57 BL/6 mice. This result indicated a pivotal role for IL-12 in the development of thyroiditis induced with CFA and mTg. In the present study we demonstrate that IL-12 deficiency does not impair EAT induction when LPS is used as adjuvant. We also demonstrate that peritoneal exudate cells from IL-12-deficient mice stimulated in vitro either with LPS or IL-18 secrete high levels of tumour necrosis factor (TNF). Together the results emphasize the difference between the use of CFA and LPS in the induction of EAT, the importance of TNF-alpha for the pathogenesis of LPS-induced EAT, and also show the capacity of IL-12-deficient mice to develop a competent response to LPS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519302      PMCID: PMC1782873          DOI: 10.1046/j.1365-2567.2003.01547.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.

Authors:  W Zhang; J C Flynn; Y C Kong
Journal:  Cell Immunol       Date:  2001-02-25       Impact factor: 4.868

Review 2.  Interleukin-18 regulates both Th1 and Th2 responses.

Authors:  K Nakanishi; T Yoshimoto; H Tsutsui; H Okamura
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Experimental autoimmune thyroiditis induced by recombinant interferon-γ.

Authors:  J J Rémy; J Salamero; M Michel-Bechet; J Charreire
Journal:  Immunol Today       Date:  1987

4.  The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease.

Authors:  P Zaccone; P Hutchings; F Nicoletti; G Penna; L Adorini; A Cooke
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

5.  Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I.

Authors:  Paola Zaccone; Zoltán Fehérvári; Lucy Blanchard; Ferdinando Nicoletti; Carl K Edwards; Anne Cooke
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

6.  Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.

Authors:  H Yokoi; K Kato; T Kezuka; J Sakai; M Usui; H Yagita; K Okumura
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

7.  Autoimmune murine thyroiditis relation to histocompatibility (H-2) type.

Authors:  A O Vladutiu; N R Rose
Journal:  Science       Date:  1971-12-10       Impact factor: 47.728

8.  Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12.

Authors:  J P Leonard; K E Waldburger; S J Goldman
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

9.  Antibodies to interleukin 12 abrogate established experimental colitis in mice.

Authors:  M F Neurath; I Fuss; B L Kelsall; E Stüber; W Strober
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

10.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.

Authors:  S Trembleau; G Penna; E Bosi; A Mortara; M K Gately; L Adorini
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  2 in total

1.  Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis.

Authors:  Kemin Chen; Yongzhong Wei; Gordon C Sharp; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2006-10-17       Impact factor: 4.962

2.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.